CancerDrs

Lymphoma clinical trials in West Virginia

4 actively recruiting lymphoma trials at 3 sites across West Virginia.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting NIH

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stag…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT05675410
Sites in West Virginia:
  • Vandalia Health/CAMC Institute for Academic Medicine — Charleston, West Virginia
  • Edwards Comprehensive Cancer Center — Huntington, West Virginia
View on ClinicalTrials.gov →
Phase 3 Recruiting Industry

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

A global multicenter, open-label, randomized and registrational Phase 3 study to evaluate efficacy and safety of olverembatinib combined with chemotherapy versus investigator's choice of tyrosine kinase inhibitor (TKI) combined with chemot…

Sponsor: Ascentage Pharma Group Inc.
NCT ID: NCT06051409
Sites in West Virginia:
  • Ascentage Investigative Site #1155 — Morgantown, West Virginia
View on ClinicalTrials.gov →
Phase 2 Recruiting Academic/Other

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

The primary objective of this research study is to evaluate the effect of tirzepatide, relative to placebo, as an adjunct to BUP on retention, substance use, and sleep outcomes in individuals with OUD.

Sponsor: T. John Winhusen, PhD
NCT ID: NCT06651177
Sites in West Virginia:
  • Marshall Health — Huntington, West Virginia
  • Healthy Minds/Chestnut Ridge — Morgantown, West Virginia
View on ClinicalTrials.gov →
Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in West Virginia:
  • Massive Bio SYNERGY-AI site — Morgantown, West Virginia
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-12